For over a decade, and as recently as August, FDA has fully evaluated the emerging scientific evidence and repeatedly ...

Kenvue stock is down 28% in 2025 amid controversy surrounding its Tylenol brand, which is linked to autism when used during ...

“For over a decade — and as recently as August — FDA has fully evaluated the emerging scientific evidence and repeatedly ...

Kenvue, the maker of Tylenol, is urging U.S. health regulators not to add an autism warning label to it and other ...

Jennifer Lawrence was 'at peace' with never returning to Hollywood after taking breaks Where are the jewels? Stolen Louvre ...

Kenvue, the maker of Tylenol, opposes proposed changes to the product's safety label regarding potential links to autism and ...

In today’s Pharmaceutical Executive Daily, we cover major leadership changes at Novo Nordisk, Kenvue’s request for the FDA to ...

Tylenol's maker, Kenvue, has strongly opposed a proposed change to the product's safety label, following research suggesting ...

Perimenopausal women who used estrogen for at least 10 years before their periods stopped had 60% lower odds for breast ...

Intuitive Surgical shares soared after the surgical robot maker posted earnings that topped expectations. Major U.S. equities indexes slid Wednesday afternoon after a flurry of weaker-than-expected ...

Johnson & Johnson stopped selling its talc-based baby powder in the US and Canada in 2020. In 2023, it switched to a cornstarch formula. The company maintains its baby powder is safe. Its consumer ...

The big news of the month is that Kering and L’Oreal have made an alliance in which Kering is selling its beauty division to L’Oreal. Kering has some major debt to sort out somewhat urgently which ...